Gut bacteria-metabolized equol shows promise in cancer prevention

FHS
July 11, 2024
5:27 am

Researchers reviewed how soy isoflavones are metabolized by gut bacteria into equol, exploring its role in cancer prevention and treatment. They examined the molecular mechanisms and gut microbiota involved to understand equol’s anti-tumor effects.

Halia’s $30M Series C; Windtree assesses ‘strategic’ options; LifeArc, Gates invest in Africa accelerator

Plus, news about Corbus and Astellas: Halia Therapeutics raises $30M Series C: The company, which is developing small molecules for inflammatory diseases, plans to use

February 1, 2024

Upcoming Changes in the Management and Supervisory Boards of the Pentixapharm Group – Biotech Investments

EQS-News: Pentixapharm Holding AG / Key word(s): Personnel Pentixapharm Holding AG: Upcoming Changes in the Management and Supervisory Boards of the Pentixapharm Group 25.10.2024 /

October 26, 2024

Biocon facility in Malaysia found to have issues once again by the FDA

A recent FDA inspection of a Biocon manufacturing facility in Malaysia has revealed more issues relating to cleanliness. The regulator inspected Biocon’s manufacturing facility in

August 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.